within Pharmacolibrary.Drugs.ATC.C;

model C05AX06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.38,
    Cl             = 2.783333333333333,
    adminDuration  = 600,
    adminMass      = 0.01,
    adminCount     = 1,
    Vd             = 0.34,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.003,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Phenylephrine is a selective alpha-1 adrenergic receptor agonist primarily used as a decongestant, vasopressor, and mydriatic agent. It is approved for use in the management of nasal congestion, hypotension (especially during anesthesia), and to dilate pupils for ophthalmic procedures. Phenylephrine is commonly available in oral, intravenous, and ophthalmic formulations and remains in use today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after a single 10 mg oral dose.</p><h4>References</h4><ol><li>Cathy K Gelotte, Dolly A Parasrampuria, Brenda A Zimmerman,Single-Dose Pharmacokinetics and Metabolism of the Oral Decongestant Phenylephrine HCl in Children and Adolescents.,Pulmonary therapy,2023<a href='https://pubmed.ncbi.nlm.nih.gov/36480111/'>https://pubmed.ncbi.nlm.nih.gov/36480111/</a></li><li>J H Hengstmann, J Goronzy,Pharmacokinetics of 3H-phenylephrine in man.,European journal of clinical pharmacology,1982<a href='https://pubmed.ncbi.nlm.nih.gov/7056280/'>https://pubmed.ncbi.nlm.nih.gov/7056280/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C05AX06;
